ArticleJournal of cellular and molecular medicine2026
Nicotinamide (Vitamin B3) Deficiency in Follicular Fluid of Patients With Ovarian Ageing.
Article in Journal of cellular and molecular medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Nicotinamide is an essential precursor of NAD involved in energy metabolism. A decline in NAD levels across tissues during ageing is well-documented, and NAD metabolism has been implicated in ovarian ageing. We investigated the relationship between ovarian ageing and the levels of nicotinamide (NAM) and its metabolite 1-methylnicotinamide (MNA) in follicular fluid (FF) and blood of IVF patients. FF was obtained from 86 patients with ovarian ageing and 82 controls. Serum samples were collected from 24 and 29 patients, respectively. Nicotinamide and 1-methylnicotinamide levels were quantified by HPLC-MS/MS. Nicotinamide concentration was significantly decrease in the FF of patients with ovarian ageing (p < 0.01), associated by an increase in 1-methylnicotinamide concentration (p = 0.01), leading to a sharp increase of the MNA/NAM ratio (p < 0.001). This ratio negatively correlated with antral follicle count, anti-Mullerian hormone level and the number of oocytes retrieved, while positively correlating with age. Additionally, there was a positive correlation between the ratio values in FF and serum. Our results suggest an imbalance towards the nicotinamide degradation pathway in ovarian ageing, potentially impairing the NAD salvage pathway. They argue in favour of using nicotinamide to counteract ovarian ageing in patients and suggest the assessment of MNA/NAM ratio as a biomarker.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.